Depatuxizumab ELISA Kit
Depatuxizumab ELISA Kit is a quantitative ELISA kit for detection of Depatuxizumab.
Depatuxizumab Mafodotin (Depatux-M; ABT-414) is an antibody-drug conjugate consisting of a specific antibody against activated EGFR and a cytotoxic agent with antimicrotubule activity. The INTELLANCE 2/EORTC 1410 phase 2 trial produced interesting results for the combination regimen of Depatux-M and temozolomide in EGFR-amplified glioblastoma patients at first recurrence. For the first time worldwide, our work investigated the clinical outcome and safety of this combination in a real-life population.
Depatuxizumab Mafodotin (Depatux-M; ABT-414) is an antibody-drug conjugate consisting of a specific antibody against activated EGFR and a cytotoxic agent with antimicrotubule activity. The INTELLANCE 2/EORTC 1410 phase 2 trial produced interesting results for the combination regimen of Depatux-M and temozolomide in EGFR-amplified glioblastoma patients at first recurrence. For the first time worldwide, our work investigated the clinical outcome and safety of this combination in a real-life population.
Supplier | Abbexa Ltd. |
---|---|
Product # | abx395009-96T |
Pricing | 96 tests USD $942.5 |
Tested Applications | ELISA |
Test Range | 0.31 μg/ml - 5 μg/ml |
CAS Number | 1471999-69-5 |
Availability | Shipped within 5-12 working days. |
Dry Ice | No |
Note |
|